Image
Veterinary
Coronavirus Vaccines
Landscape
About the Landscape
The Veterinary Coronavirus Vaccines Landscape compiles and summarizes publicly available information on coronavirus vaccines that are in development and commercially available for domesticated animals.
Improved coronavirus vaccines for domesticated companion and agricultural animals are intended to provide improved protection from disease, reduce animal suffering, prevent viral transmission to offspring, respond to the emergence of highly virulent strains, and enhance global food and livelihood security. Vaccine candidates profiled in the Landscape span all four coronavirus genera and multiple animal species.
CIDRAP initiated development of the Landscape with data from the University of Bergen and support from CEPI, the Coalition for Epidemic Preparedness Innovations.
Recent Updates
Sep 9, 2026 - The CIDRAP Coronavirus Vaccines R&D Roadmap (CVR) Initiative launched the Veterinary Coronavirus Vaccines Landscape.
Database
No candidates match your search.
| Developer | Approach | |||||
|---|---|---|---|---|---|---|
| Zoetis (US) | Gammacoronaviruses | Commercially Available |
|
Live-attenuated | ||
| Zoetis (US) | Gammacoronaviruses | Commercially Available |
|
Inactivated | ||
| Zoetis (US) | Gammacoronaviruses | Commercially Available |
|
Inactivated | ||
| Zoetis (US) | Gammacoronaviruses | Commercially Available |
|
Live-attenuated | ||
| Zoetis (US) | Gammacoronaviruses | Commercially Available |
|
Live-attenuated | ||
| Zoetis (US) | Gammacoronaviruses | Commercially Available |
|
Live-attenuated | ||
| Zoetis (US) | Gammacoronaviruses | Commercially Available |
|
Live-attenuated | ||
| Zoetis (US) | Gammacoronaviruses | Commercially Available |
|
Live-attenuated | ||
| Zoetis (US) | Gammacoronaviruses | Commercially Available |
|
Live-attenuated | ||
| Zoetis (US) | Gammacoronaviruses | Commercially Available |
|
Live-attenuated | ||
| Zoetis (US) | Gammacoronaviruses | Commercially Available |
|
Live-attenuated | ||
| Veterinary Serum and Vaccine Research Institute (Egypt) | Gammacoronaviruses | Commercially Available | 2025 |
|
Live-attenuated | |
| Nanchang Boehringer Ingelheim Animal Health (China) | Gammacoronaviruses | Commercially Available | 2025 |
|
Live-attenuated | |
| MEVAC (Middle East Vaccine Company) (Egypt) | Gammacoronaviruses | Commercially Available | 2025 |
|
Live-attenuated | |
| MEVAC (Middle East Vaccine Company) (Egypt) | Gammacoronaviruses | Commercially Available | 2025 |
|
Live-attenuated | |
| Merck Animal Health (US) | Gammacoronaviruses | Commercially Available | 2026 |
|
Inactivated | |
| Merck Animal Health (US) | Gammacoronaviruses | Commercially Available |
|
Live-attenuated | ||
| Merck Animal Health (US) | Gammacoronaviruses | Commercially Available |
|
Live-attenuated | ||
| Merck Animal Health (US) | Gammacoronaviruses | Commercially Available |
|
Inactivated | ||
| Merck Animal Health (US) | Gammacoronaviruses | Commercially Available |
|
Live-attenuated | ||
| Merck Animal Health (US) | Gammacoronaviruses | Commercially Available |
|
Live-attenuated | ||
| Genera, Inc. (Dechra Pharmaceuticals) (Croatia) | Gammacoronaviruses | Commercially Available | 2025 |
|
Live-attenuated | |
| Genera, Inc. (Dechra Pharmaceuticals) (Croatia) | Gammacoronaviruses | Commercially Available | 2026 |
|
Live-attenuated | |
| Genera, Inc. (Dechra Pharmaceuticals) (Croatia) | Gammacoronaviruses | Commercially Available | 2026 |
|
Live-attenuated | |
| Ceva Animal Health (US) | Gammacoronaviruses | Commercially Available | 2026 |
|
Live-attenuated | |
| Ceva Animal Health (US) | Gammacoronaviruses | Commercially Available | 2026 |
|
Live-attenuated | |
| Ceva Animal Health (US) | Gammacoronaviruses | Commercially Available |
|
Inactivated | ||
| Ceva Animal Health (US) | Gammacoronaviruses | Commercially Available |
|
Live-attenuated | ||
| Ceva Animal Health (US) | Gammacoronaviruses | Commercially Available |
|
Live-attenuated | ||
| Boehringer Ingelheim Animal Health (US) | Gammacoronaviruses | Commercially Available |
|
Live-attenuated | ||
| Boehringer Ingelheim Animal Health (US) | Gammacoronaviruses | Commercially Available |
|
Live-attenuated | ||
| Boehringer Ingelheim Animal Health (US) | Gammacoronaviruses | Commercially Available |
|
Live-attenuated | ||
| Boehringer Ingelheim Animal Health (US) | Gammacoronaviruses | Commercially Available |
|
Live-attenuated | ||
| Boehringer Ingelheim Animal Health (US) | Gammacoronaviruses | Commercially Available |
|
Live-attenuated | ||
| Boehringer Ingelheim Animal Health (US) | Gammacoronaviruses | Commercially Available |
|
Inactivated | ||
| Boehringer Ingelheim Animal Health (US) | Gammacoronaviruses | Commercially Available |
|
Live-attenuated | ||
| Boehringer Ingelheim Animal Health (US) | Gammacoronaviruses | Commercially Available |
|
Live-attenuated | ||
| Boehringer Ingelheim Animal Health (US) | Gammacoronaviruses | Commercially Available |
|
Live-attenuated | ||
| Tianjin Agricultural University (China) | Gammacoronaviruses | Clinical | 2025 |
|
DNA | |
| The Arab Pesticides and Veterinary Drugs Manufacturing Company (Jordan), Jordan University of Science and Technology (Jordan) | Gammacoronaviruses | Clinical | 2026 |
|
DNA | |
| South China Agricultural University (China), Zhaoqing Branch of Guangdong Laboratory of Lingnan Modern Agricultural Science and Technology (China) | Gammacoronaviruses | Clinical | 2025 |
|
Nanoparticle | |
| Sichuan University (China) | Gammacoronaviruses | Clinical | 2025 |
|
Viral vector | |
| Chinese Academy of Sciences (China) | Gammacoronaviruses | Clinical | 2025 |
|
Plant-based | |
| Beijing University of Agriculture (China) | Gammacoronaviruses | Clinical | 2026 |
|
mRNA | |
| Zoetis (US) | Betacoronaviruses | Commercially Available | 2025 |
|
Protein subunit | |
| Merck Animal Health (US) | Betacoronaviruses | Commercially Available |
|
Inactivated | ||
| Merck Animal Health (US) | Betacoronaviruses | Commercially Available |
|
Inactivated | ||
| Boehringer Ingelheim Animal Health (US) | Betacoronaviruses | Commercially Available |
|
Inactivated | ||
| Southwest Minzu University (China) | Betacoronaviruses | Clinical | 2024 |
|
Virus-like particle | |
| Chinese Academy of Agricultural Sciences (China) | Betacoronaviruses | Clinical | 2025 |
|
Viral vector | |
| Xinjiang Agricultural University (China) | Betacoronaviruses | Preclinical | 2025 |
|
mRNA | |
| University of Cape Town (South Africa) | Betacoronaviruses | Preclinical | 2025 |
|
Viral vector | |
| Ministry of Agriculture Viral Disease Research Division (South Korea) | Alphacoronaviruses | Commercially Available | 2018 |
|
Inactivated | |
| Elanco (US) | Alphacoronaviruses | Commercially Available |
|
Inactivated | ||
| Elanco (US) | Alphacoronaviruses | Commercially Available |
|
Inactivated | ||
| Wuhan University (China) | Alphacoronaviruses | Clinical | 2023 |
|
Viral vector | |
| Wenzhou University (China), Chinese Academy of Agricultural Sciences (China), Jilin University (China) | Alphacoronaviruses | Clinical | 2026 |
|
Bacterial vector | |
| Virginia Polytechnic Institute and State University (US) | Alphacoronaviruses | Clinical | 2020 |
|
Virus-like particle | |
| Vietnam Academy of Science and Technology (Vietnam), JSC Central Veterinary NAVETCO (Vietnam), Leibniz Institute of Plant Genetics and Crop Plant Research (Germany) | Alphacoronaviruses | Clinical | 2022 |
|
Plant-based | |
| University of Virginia (US), Virginia Polytechnic Institute and State University (US) | Alphacoronaviruses | Clinical | 2021 |
|
Inactivated | |
| The Pirbright Institute (UK), University of Surrey (UK) | Alphacoronaviruses | Clinical | 2026 |
|
Viral vector | |
| Sun Yat-sen University (China) | Alphacoronaviruses | Clinical | 2018 |
|
Protein subunit | |
| Southwest Minzu University (China) | Alphacoronaviruses | Clinical | 2024 |
|
Viral vector | |
| Southwest Minzu University (China) | Alphacoronaviruses | Clinical | 2025 |
|
Viral vector | |
| Southwest Minzu University (China) | Alphacoronaviruses | Clinical | 2024 |
|
Virus-like particle | |
| South China Agricultural University (China) | Alphacoronaviruses | Clinical | 2026 |
|
Protein subunit | |
| South China Agricultural University (China) | Alphacoronaviruses | Clinical | 2023 |
|
Virus-like particle | |
| Sichuan University (China) | Alphacoronaviruses | Clinical | 2026 |
|
mRNA | |
| Shanxi Agricultural University (China), Shanxi Academy of Advanced Research and Innovation (China) | Alphacoronaviruses | Clinical | 2026 |
|
Nanoparticle | |
| Shanghai ShenLian Biomedical Corporation (China) | Alphacoronaviruses | Clinical | 2026 |
|
Inactivated | |
| Shanghai Jiao Tong University (China) | Alphacoronaviruses | Clinical | 2019 |
|
Viral vector, Protein subunit | |
| Northwest A&F University (China), Engineering Research Center of Efficient New Vaccines for Animals (China), Hangzhou ISEEVAX Pharmaceutical Technology Co., Ltd. (China) | Alphacoronaviruses | Clinical | 2026 |
|
Self-amplifying RNA | |
| Northeast Agricultural University (China) | Alphacoronaviruses | Clinical | 2022 |
|
Bacterial vector | |
| National Taiwan University (Taiwan), Chung Yuan Christian University (Taiwan) | Alphacoronaviruses | Clinical | 2020 |
|
Virus-like particle | |
| National Taiwan University (Taiwan) | Alphacoronaviruses | Clinical | 2020 |
|
Inactivated | |
| National Pingtung University of Science and Technology (Taiwan) | Alphacoronaviruses | Clinical | 2026 |
|
DNA | |
| Nanyang Normal University (China), Nanyang Vocational College of Science and Technology (China) | Alphacoronaviruses | Clinical | 2025 |
|
Nanoparticle | |
| Nanyang Normal University (China) | Alphacoronaviruses | Clinical | 2025 |
|
mRNA | |
| Nanjing Tech University (China), Jiangsu Academy of Agricultural Sciences (China), Yangzhou University (China) | Alphacoronaviruses | Clinical | 2026 |
|
Live-attenuated | |
| Nanjing Agricultural University (China) | Alphacoronaviruses, Deltacoronaviruses | Clinical | 2025 |
|
Inactivated | |
| Jinyu Baoling Bio-pharmaceutical Co. (China), China Agricultural University (China) | Alphacoronaviruses | Clinical | 2026 |
|
Protein subunit | |
| Jiangxi Agricultural University (China) | Alphacoronaviruses | Clinical | 2020 |
|
Inactivated | |
| Jiangsu Academy of Agricultural Sciences (China) | Alphacoronaviruses | Clinical | 2020 |
|
Inactivated | |
| Jiangsu Academy of Agricultural Sciences (China) | Alphacoronaviruses | Clinical | 2026 |
|
mRNA, Virus-like particle | |
| Jiangsu Academy of Agricultural Sciences (China) | Alphacoronaviruses | Clinical | 2024 |
|
Protein subunit | |
| Jiangsu Academy of Agricultural Sciences (China) | Alphacoronaviruses | Clinical | 2024 |
|
Protein subunit | |
| Jiangsu Academy of Agricultural Sciences (China) | Alphacoronaviruses | Clinical | 2024 |
|
mRNA | |
| Iowa State University (US), Zoetis (US) | Alphacoronaviruses | Clinical | 2022 |
|
Live-attenuated | |
| Huazhong Agricultural University (China) | Alphacoronaviruses | Clinical | 2025 |
|
Protein subunit | |
| Huazhong Agricultural University (China) | Alphacoronaviruses | Clinical |
|
Inactivated | ||
| Henan Agricultural University (China) | Alphacoronaviruses | Clinical | 2024 |
|
Viral vector | |
| Henan Agricultural University (China) | Alphacoronaviruses | Clinical | 2024 |
|
Protein subunit | |
| Heilongjiang Bayi Agricultural University (China) | Alphacoronaviruses | Clinical | 2024 |
|
Nanoparticle | |
| Guangxi University (China), NanoRibo (Shanghai) Biotechnology Co. Ltd. (China) | Alphacoronaviruses | Clinical | 2026 |
|
mRNA | |
| Guangdong Laboratory for Lingnan Modern Agriculture (China), Sun Yat-sen University (China), South China Agricultural University (China) | Alphacoronaviruses | Clinical | 2025 |
|
Protein subunit | |
| Chinese Academy of Agricultural Sciences (China), Gansu Province Research Center for Basic Disciplines of Pathogen Biology (China) | Alphacoronaviruses | Clinical | 2024 |
|
Nanoparticle | |
| Chinese Academy of Agricultural Sciences (China) | Alphacoronaviruses | Clinical | 2025 |
|
Viral vector | |
| Chinese Academy of Agricultural Sciences (China) | Alphacoronaviruses | Clinical | 2024 |
|
Viral vector | |
| California Polytechnic State University (US), Veterinary Resources, Inc. (US) | Alphacoronaviruses | Clinical | 2021 |
|
Plant-based | |
| BioApplications, Inc. (South Korea), Korea Research Institute of Bioscience and Biotechnology (South Korea), Kangwon National University (South Korea), Jeonbuk National University (South Korea) | Alphacoronaviruses | Clinical | 2023 |
|
Plant-based | |
| University of Saskatchewan (Canada) | Alphacoronaviruses | Preclinical | 2026 |
|
Protein subunit | |
| University of California, Davis (US) | Alphacoronaviruses | Preclinical | 2024 |
|
mRNA | |
| Shihezi University (China) | Alphacoronaviruses | Preclinical | 2025 |
|
Protein subunit | |
| Shanxi Agricultural University (China), Shanxi Academy of Advanced Research and Innovation (China) | Alphacoronaviruses | Preclinical |
|
circRNA | ||
| Shanghai Jiao Tong University (China) | Alphacoronaviruses | Preclinical | 2026 |
|
Bacteriophage | |
| Shandong Academy of Agricultural Sciences (China) | Alphacoronaviruses, Deltacoronaviruses | Preclinical | 2026 |
|
mRNA | |
| Northeast Agricultural University (China) | Alphacoronaviruses | Preclinical | 2026 |
|
Bacterial vector | |
| Jilin University (China), Changchun University (China) | Alphacoronaviruses | Preclinical | 2026 |
|
Virus-like particle | |
| Jiangsu Academy of Agricultural Sciences (China) | Alphacoronaviruses | Preclinical | 2026 |
|
Protein subunit | |
| Jeonbuk National University (South Korea) | Alphacoronaviruses | Preclinical | 2026 |
|
Bacterial vector | |
| Henan Agricultural University (China) | Alphacoronaviruses | Preclinical | 2025 |
|
Inactivated | |
| Hebei Normal University of Science and Technology (China) | Alphacoronaviruses | Preclinical | 2026 |
|
Bacterial vector | |
| Guizhou University (China) | Alphacoronaviruses | Preclinical | 2026 |
|
Protein subunit | |
| China Agricultural University (China) | Gammacoronaviruses | Clinical | 2026 |
|
mRNA | |
| Guangxi University (China) | Gammacoronaviruses | Clinical | 2026 |
|
Inactivated | |
| MEVAC (Middle East Vaccine Company) (Egypt) | Gammacoronaviruses | Commercially Available |
|
Inactivated | ||
| MEVAC (Middle East Vaccine Company) (Egypt) | Gammacoronaviruses | Commercially Available |
|
Inactivated | ||
| MEVAC (Middle East Vaccine Company) (Egypt) | Gammacoronaviruses | Commercially Available |
|
Inactivated | ||
| MEVAC (Middle East Vaccine Company) (Egypt) | Gammacoronaviruses | Commercially Available |
|
Inactivated | ||
| MEVAC (Middle East Vaccine Company) (Egypt) | Gammacoronaviruses | Commercially Available |
|
Inactivated | ||
| MEVAC (Middle East Vaccine Company) (Egypt) | Gammacoronaviruses | Commercially Available |
|
Inactivated | ||
| Merck Animal Health (US) | Gammacoronaviruses | Commercially Available |
|
Inactivated | ||
| Merck Animal Health (US) | Gammacoronaviruses | Commercially Available |
|
Inactivated | ||
| Elanco (US) | Betacoronaviruses | Commercially Available |
|
Inactivated | ||
| Elanco (US) | Betacoronaviruses | Commercially Available |
|
Inactivated | ||
| Zoetis (US) | Betacoronaviruses | Commercially Available |
|
Inactivated | ||
| Zoetis (US) | Betacoronaviruses | Commercially Available | 2024 |
|
Inactivated | |
| Elanco (US) | Alphacoronaviruses | Commercially Available |
|
Inactivated | ||
| Elanco (US) | Alphacoronaviruses | Commercially Available |
|
Inactivated | ||
| Elanco (US) | Alphacoronaviruses | Commercially Available |
|
Inactivated | ||
| Anhui Agricultural University (China) | Deltacoronaviruses | Preclinical | 2025 |
|
Virus-like particle | |
| Chinese Academy of Agricultural Sciences (China) | Deltacoronaviruses | Clinical | 2025 |
|
mRNA | |
| Hunan Agricultural University (China) | Deltacoronaviruses | Clinical | 2025 |
|
Nanoparticle | |
| Chinese Academy of Agricultural Sciences (China) | Deltacoronaviruses | Clinical | 2019 |
|
Inactivated | |
| Sichuan Agricultural University (China) | Deltacoronaviruses | Clinical | 2023 |
|
Viral vector | |
| Sichuan Agricultural University (China) | Deltacoronaviruses | Clinical | 2025 |
|
Bacterial vector | |
| Henan Agricultural University (China) | Deltacoronaviruses | Preclinical | 2022 |
|
Inactivated | |
| Jiangsu Academy of Agricultural Sciences (China) | Deltacoronaviruses | Clinical | 2024 |
|
Protein subunit | |
| Jiangsu Academy of Agricultural Sciences (China) | Deltacoronaviruses | Clinical | 2023 |
|
Protein subunit | |
| Chinese Academy of Agricultural Sciences (China) | Deltacoronaviruses | Preclinical | 2024 |
|
Nanoparticle | |
| Jiangsu Academy of Agricultural Sciences (China), Nanjing Agricultural University (China), Zhejiang Hongsheng Biotechnology Co. (China) | Deltacoronaviruses | Clinical | 2024 |
|
Inactivated | |
| Jiangsu Academy of Agricultural Sciences (China) | Deltacoronaviruses | Clinical | 2024 |
|
Virus-like particle | |
| University of Oxford (UK), King Abdullah International Medical Research Center (Saudi Arabia), Ministry of Environment, Water and Agriculture (Saudi Arabia), International Vaccine Institute (South Korea), King Abdulaziz University (Saudi Arabia), Philipps University of Marburg (Germany) | Betacoronaviruses | Clinical | 2019 |
|
Viral vector | |
| IDT Biologika (Germany), German Center for Infection Research (Germany), University of Hamburg-Eppendorf (Germany) | Betacoronaviruses | Clinical | 2023 |
|
Viral vector | |
| PioneerVaccine Inc. (South Korea), Kyunpook National University (South Korea) | Betacoronaviruses | Preclinical | 2024 |
|
Inactivated | |
| PioneerVaccine Inc. (South Korea), Kyunpook National University (South Korea) | Betacoronaviruses | Preclinical | 2023 |
|
Live-attenuated | |
| Zoetis (US), Iowa State University (US) | Alphacoronaviruses | Commercially Available | 2017 |
|
Inactivated | |
| University of Iowa (US), University of Georgia (US) | Betacoronaviruses | Preclinical | 2020 |
|
Viral vector | |
| Zoetis (US) | Alphacoronaviruses | Commercially Available |
|
Inactivated | ||
| Zoetis (US) | Betacoronaviruses | Commercially Available | 2024 |
|
Live-attenuated | |
| Zoetis (US) | Alphacoronaviruses | Commercially Available |
|
Live-attenuated | ||
| Merck Animal Health (US) | Betacoronaviruses | Commercially Available | 2026 |
|
Live-attenuated | |
| Jiangsu Academy of Agricultural Sciences (China) | Deltacoronaviruses | Clinical | 2024 |
|
mRNA | |
| Merck Animal Health (US) | Gammacoronaviruses | Commercially Available |
|
Inactivated | ||
| Chinese Academy of Agricultural Sciences (China) | Betacoronaviruses | Clinical | 2022 |
|
Viral vector | |
| Merck Animal Health (US) | Alphacoronaviruses | Commercially Available |
|
Inactivated |
